Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome
Condition(s):Guillain-Barre SyndromeLast Updated:November 15, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Guillain-Barre SyndromeLast Updated:November 15, 2023Not yet recruiting
Condition(s):Haemolysis NeonatalLast Updated:June 27, 2017Unknown status
Condition(s):Small Fiber NeuropathyLast Updated:July 5, 2019Completed
Condition(s):Burn ShockLast Updated:November 15, 2022Completed
Condition(s):Secondary Recurrent MiscarriageLast Updated:November 6, 2014Completed
Condition(s):Solar UrticariaLast Updated:July 30, 2013Completed
Condition(s):Multiple System AtrophyLast Updated:February 23, 2017Completed
Condition(s):Chronic Idiopathic Thrombocytopenic PurpuraLast Updated:March 1, 2013Completed
Condition(s):HIV-associated MyelopathyLast Updated:April 13, 2018Terminated
Condition(s):Complex Regional Pain Syndrome Type 1Last Updated:July 15, 2021Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.